sulfanilamide has been researched along with Diabetes Mellitus, Type 1 in 4 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
WATT, JG | 1 |
CHUTE, AL | 1 |
BAIN, HW | 1 |
NEWCOMB, AL | 1 |
TRAISMAN, HS | 1 |
BARTA, L | 1 |
4 other studies available for sulfanilamide and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Treatment of unstable diabetes mellitus with BZ-55 and insulin.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Insulin; Sulfanilamide; Sulfanilamides; Sulfonamides; | 1956 |
Experiences with oral sulfonamide (BZ-55) in the management of juvenile diabetes.
Topics: Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Disease Management; Humans; Infant; Sulfanilami | 1956 |
Effect of carbutamide in juvenile diabetes mellitus.
Topics: Carbutamide; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Infant; Sulfanilamide; Sul | 1957 |
Carbutamide in juvenile diabetes.
Topics: Carbutamide; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Infant; Sulfanilamide; Sulfanilami | 1957 |